The U.S. Podiatry Registry was created in 2015 in response to the ongoing need of Podiatrists to aggregate data about our patients to support the public policy attacks against our specialty. Every day CMS and private payers must find ways to cut costs to the Medicare and private health care system. We have evolved into a world where you must justify the basis for your fees, or watch them be cut, often dramatically.
Recently, the U.S. Hyperbaric Industry almost vanished overnight. The AMA's RUC was reviewing the justification for the basis of the hyperbaric physician in attendance code, and without supporting data to back up claims of "our patients are ill and need these advanced services" the relative value rate for that service was set for a significant reduction. The U.S. Hyperbaric Registry provided concrete, real world experience based data to support the hyperbaricists arguments and the value rates, while lower, were nowhere near where they were originally headed, averting a tragic payment impact. The USPR is one of nine (9) registries maintained by the Chronic Disease Registry. The CDR is a Qualified Clinical Data Registry (QCDR) recognized by CMS in 2013 and has been a PQRS Registry since 2007.
Measurement under the Merit Based Incentive Payment System (MIPS) is currently scheduled to begin January 1, 2017 to determine Medicare Part B reimbursement for the calendar year 2019. CMS estimates that only 4% of practitioners will be participating in Alternative Payment Models, so 96% of practitioners will have their Medicare Part B payments determined by MIPS performance, and that includes all podiatrists. Unless implementation is delayed, this means that within a few months, podiatrists must be prepared to succeed under the MIPS structure.
MIPS program penalties will result in a podiatrist losing 4% of his or her Medicare Part B payments unless they succeed at transitioning to this new system. However, under the current structure, podiatrists can achieve as much as a 12% BONUS in Medicare Part B payments within the first year. The percentage of your Part B payment at risk (and your ability to experience a bonus) changes each year so that by 2022, you could experience -9%, or +27%! Learn More »
The Chronic Disease Registry, a CMS-recognized QCDR, operates a family of 9 registries serving underrepresented patient populations. Click on a registry below to learn more.
The CDR is a 501(c)(3) tax-exempt organization. As a nonprofit corporation and a tax-exempt organization, the CDR is subject to restrictions to ensure its assets are used in furtherance of its charitable mission and not for private gain. Its mission and purpose is to create and operate data registries of patient data, chronic diseases, medical products and devices. Each registry within CDR is governed by its own unique data governance board.